Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Abiomed gets EU approval for Impella heart pump

April 12, 2012 By Business Wire

DANVERS,
Mass., (BUSINESS
WIRE) —Abiomed,
Inc
, a leading provider of break-through heart support technologies, today
announced it has received CE Marking approval in the European Union to market
the Impella cVAD device, a new percutaneous Impella(R) heart pump that provides
peak flow of approximately 4 liters of blood per minute.

The Impella cVAD1 is designed to provide temporary
circulatory support via a minimally invasive, catheter-based pump that is
inserted percutaneously, without the need for surgical intervention.

The Impella cVAD further enhances Abiomed’s product
portfolio, providing physicians with the clinical flexibility to offer
increased flow for patients requiring more hemodynamic support. The increased
flow is delivered on the same console platform, 9 French catheter, and introducer
as the Impella 2.5.

“We are proud to announce the commercial European
availability of the new Impella cVAD device and the growing Abiomed product
portfolio,” said Michael R. Minogue, Chairman, President and Chief
Executive Officer, Abiomed.

Full commercial availability of the Impella cVAD in the
European market is expected by summer 2012.

The Impella cVAD is not currently cleared for sale or use in
the United States.

1According to the labeling under CE Mark in Europe and other
countries, the Impella cVAD (intracardiac pump for supporting the left
ventricle) is intended for clinical use in cardiology and cardiac surgery for
up to 5 days for the following indications, as well as others: the Impella cVAD
is a circulatory support system for patients with reduced left ventricular
function, e.g., post-cardiotomy, low output syndrome, cardiogenic shock after
acute myocardial infarction, or for myocardial protection after acute
myocardial infarction; the Impella cVAD may also be used as a cardiovascular
support system during coronary bypass surgery on the beating heart,
particularly in patients with limited preoperative ejection fraction with a
high risk of postoperative low output syndrome; support during high risk
percutaneous coronary intervention (PCI); post PCI.

ABOUT ABIOMED

Based in Danvers, Massachusetts, Abiomed, Inc., is a leading
provider of medical devices that provide circulatory support. Our products are
designed to enable the heart to rest by improving blood flow and/or performing
the pumping of the heart. For additional information please visit: www.abiomed.com.

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech